|
|
 |
|
Viewing report
|
|
|
|
The Vaccines Market Outlook: Market Analysis Of Future Growth And Leading Players By Sector
Business Insights, Jan 2005
This new report provides a detailed analysis of the vaccines market in the US and the five major European markets and also reviews some of the most promising products in development, highlighting those expected to drive market growth in the future and in some cases become the first vaccine to market for a disease.
The market for vaccines is broken down by population (pediatric and adult) and also by disease area. A comprehensive competitive overview is provided with an examination of key brands together with profiles of the leading players in this market.
Vaccines factfile - know your market
This report provides:
- Sales breakdown of the vaccines market into pediatric and adult vaccines, as well as disease area and compound annual growth rates.
- Company analysis and market share of vaccine market, including GSK, Merck & Co, Sanofi-Aventis, Wyeth and Chiron.
- Strategic analysis of all major vaccine brands, such as Pediarix, MMR II, Prevnar, Varivax, Recombivax HB and Fluvirin.
- An examination of differences in the diseases routinely vaccinated against in the US and European countries, and how the market are affected by this.
- A review of the future growth drivers in the market, such as the growing market for adult vaccination and the development of vaccines against STDs (HPV, genital herpes and HIV).
Top 5 reasons to order your copy today…
- Compare and contrast your company's vaccines pipeline against your top competitors, assess the strength of your pipeline and identify the potential opportunities you can exploit.
- Increase your vaccines market share by identifying where the major growth opportunities lie and which sectors will provide the greatest return on investment.
- Tailor your strategy to both US and European markets by understanding the differences between the countries and meeting the needs of each geographical market.
- Compare sales data and company-reported data for the vaccines market.
- Define the optimum position for your company in the vaccines market, by understanding who your main competitors are and assessing strengths and weaknesses of their market strategy.
Hot issues covered in this report
HPV vaccines and treatments:
The HPV virus linked to 99% of cervical cancers, the second leading cause of death amongst woman. There are 2 vaccines in mid-late stage development, one from Merck and the other called Cervarix from GSK. An efficacious vaccine for HPV would have a large market, both for year-on-year vaccination and for catch-up vaccination. It would also command a high price point and could prove to be very lucrative.
Vaccine safety (particularly MMR):
There has been much controversy in recent years surrounding the safety of vaccine and particularly the link of autism to MMR vaccination.
Epidemiology data is provided showing the benefits of vaccination in providing 'herd immunity' and the reduction in disease incidence. This reduction is in threat with the increasing number of parents refusing to have their children vaccinated.
Influenza vaccine shortage in 2004 and 2005:
The much publicised influenza vaccine shortage in 2004/2005 is a result of the suspension of production of major influenza vaccine supplier, Chiron, due to the discovery of GMP failures at its Liverpool plant. The impact of this suspension on Chiron, and its rival in the influenza vaccine market, Sanofi-Aventis, is discussed.
Year round production of Sanofi-Aventis' Fluzone
Chiron's loss in the influenza market is Sanofi-Aventis' gain, as the company has recently been awarded a US government contract to start year-round production of Fluzone.
Your questions answered
- Which vaccine populations will drive growth in the future?
- Which disease areas will drive growth in the future?
- In what disease area does vaccination generate the most revenue?
- Which vaccines are included in the paediatric immunization schedules in the US and Europe, and how are product sales affected by this?
- What are the key brands in the vaccines market, and how was their success
achieved?
- Who are the key players in the vaccines market currently and who will be the leading players in the future?
- What company has the strongest vaccines portfolio and is likely to be the market leader in 2010?
Customers who bought this item also bought
Infectious Diseases Vaccine Market Overview: Key Companies & Strategies - In Times of Crisis, Big Pharma turns to Vaccines
Human Vaccines - Global Strategic Business Report
Pipeline and Commercial Insight: Pediatric and Adolescent Vaccines
Pipeline And Commercial Insight: Influenza Vaccines - Pandemic Threat Revitalizes The Sector
Human Vaccines - Global Market Opportunities
Product Pinpoint: The New Vaccines
Global Vaccine Market Forecast to 2012
World Vaccines Market 2008-2013: Future Forecast, Critical Trends and Developments
Global Vaccine Market Outlook (2007-2010)
Indian Vaccines Report
Vaccines Market Insight: Products, Pipelines & Market Outlook
Pipeline Perspectives: Vaccines - Expanding Portfolio Diversity
|
|
|
|
